Biovie Inc (BIVI NASDAQ) stock market data APIs
$1.3336
-0.09(-6.7%)
as of November 6, 2026
Try our APIs with
free plan!
Biovie Inc Financial Data Overview
Price chart is built with
Anychart
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 3 for the treatment of life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism. It also develops Bezisterim, an investigational, novel, orally administered small molecule that is In Phase 3 clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2b clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Prev. Close
1.3336
Open
1.2451
High
1.3851
Low
1.2359
52 wk Range
0.82-3.79
Market Cap
12 836 K
Shares Outstanding
9 651 K
Beta
0.796
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Biovie Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Biovie Inc data using free add-ons & libraries
Get Biovie Inc Fundamental Data
Biovie Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -22 473 392
- Earnings Per Share: -3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-11-09
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Biovie Inc News
New
Fusion Power, Global Capital, Branded Streaming and Neurology Breakthroughs: New to The Street Show #779 Premieres Tonight on Bloomberg Television
American Fusion (OTCQB:AMFN), FreeCast (NASDAQ:CAST), Stewards Investment Capital and BioVie (NASDAQ:BIVI) Headline a Four-Region Broadcast Across the U.S., Latin America, MENA and Southeast Asia NEW...
From Global Private Credit to Programmable Securities: New to The Street Show #778 Premieres Tonight on Bloomberg Television
Stewards Investment Capital, FreeCast (NASDAQ:CAST) and BioVie (NASDAQ:BIVI) Headline a Four-Region Broadcast Across the U.S., Latin America, MENA and Southeast Asia NEW YORK CITY, NY / ACCESS Newswi...
From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television
Stewards Investment Capital, BioVie, FreeCast and American Fusion Headline a Four-Region Broadcast Across the U.S., Latin America, MENA and Southeast Asia NEW YORK CITY, NY / ACCESS Newswire / Octobe...
New to The Street Show 773 Premieres Tonight on Bloomberg Television, Featuring Glint, Sagtec Global, BioVie and SafeSpace Global
Gold-backed payments, enterprise AI, a Long COVID clinical readout and AI-powered school safety lead a 6:30 p.m. ET broadcast reaching audiences across the United States, Latin America and MENA NEW Y...
Get Biovie Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.